D3: Honoka Obata

  • Date of Birth May 6
  • Place of Birth Takamatsu Kagawa

Education

  • 2014.4. - 2018.3.Faculty of Sciences, Hokkaido University, Sapporo, Japan
  • 2018.4. - 2020.3.Graduate School of Sciences, Osaka University, Osaka, Japan
  • 2020.4. - presentGraduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan

Research Experience

  • 2017.4.Business Assistant, National Institute of Radiological Sciecnes, National Institutes for Quantum and Radiological Science and Technology
  • 2018.10Research Assistant, National Institute of Radiological Sciecnes, National Institutes for Quantum and Radiological Science and Technology
  • 2020.4.Research Fellow, the Japan Society for the Promotion of Science (DC1, ~2023.3)

Certification

  • 2016.10.First Class Radiation Protection Supervisor, Passed (#26618)

Membership of Academic Societies

The Japan Society of Nuclear and Radiochemical Sciences

Honors and Awards

  • 2018.9.CJKSRS2018 Travel Grant (第2回日本核医学会分科会放射薬品科学研究会)
  • 2018.11.Young Investigator Award (The 10th China-Japan-Korea Symposium on Radiopharmaceutical Sciences)
  • 2019.9.Young Investigator Award (日本放射化学会第63回討論会)
  • 2021.7.Young Investigator Award (The 58th Annual Meeting on Radioisotopes and Radiation Researches)

Publications

  1. Khandaker MU, Chakraborty AK, Nagatsu K, Obata H, Minegishi K, Zhang MR, Okhunov AA. The formation of isomeric pair in the natTi(3He,x)44m,gSc reactions: Effect of spin cut-off parameter on the isomeric ratio. Nucl Instrum Methods Phys Res, Sect B 2021, 499, 1-6.
  2. Shirakami Y, Watabe T, Obata H, Kaneda K, Ooe K, Liu Y, Teramoto T, Toyoshima A, Shinohara A, Shimosegawa E, Hatazawa J, Fukase K. Synthesis of [211At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution. Sci Rep 2021, 11 (1), 12982.
  3. Matsuoka K, Obata H, Nagatsu K, Kojima M, Yoshino T, Ogawa M, Matsunaga S. Transition-metal-free nucleophilic 211At-astatination of spirocyclic aryliodonium ylides. Org Biomol Chem 2021, 19 (25), 5525-5528.
  4. Obata H, Tsuji AB, Sudo H, Sugyo A, Minegishi K, Nagatsu K, Ogawa M, Zhang MR. In Vitro Evaluation of No-carrier-added Radiolabeled Cisplatin ([189, 191Pt]cisplatin) Emitting Auger Electrons. Int J Mol Sci 2021, 22, 4622.
  5. Obata H, Minegishi K, Nagatsu K, Ogawa M, Zhang MR. Synthesis of no-carrier-added [188, 189, 191Pt]cisplatin from a cyclotron produced 188, 189, 191PtCl4(2-) complex. Sci Rep 2021, 11, 8140.
  6. Toyoshima A, Nagata K, Ooe K, Zhang Z, Ikeda T, Ichimura S, Obata H, Yoshimura T, Shinohara A. Dispersal rates of astatine-211 from aqueous solutions and chloroform. Radiation Safety Management 2019, 18, 16-22.
  7. Obata H, Minegishi K, Nagatsu K, Zhang MR, Shinohara A. Production of 191Pt from an iridium target by vertical beam irradiation and simultaneous alkali fusion. Appl Radiat Isot 2019, 149, 31-37.
  8. Khandaker MU, Nagatsu K, Obata H, Minegishi K, Zhang MR. Excitation functions of helion-induced nuclear reactions on natural titanium up to 55MeV. Nucl Instrum Methods Phys Res Sect B 2019, 445, 69-76.
  9. Obata H, Khandaker MU, Furuta E, Nagatsu K, Zhang MR. Excitation functions of proton- and deuteron-induced nuclear reactions on natural iridium for the production of 191Pt. Appl Radiat Isot 2018, 137, 250-260.

Presentations

  1. 尾幡穂乃香, 永津弘太郎, 辻厚至, 小川美香子, 張明栄. 加速器を用いた白金核種(191Pt)の製造および標識白金錯体の合成. 第58回アイソトープ・放射線研究発表会, 7/7-9, 29005-06-02, online, 2021.7.8. (Oral)
  2. 尾幡穂乃香, 白神宜史, 兼田加珠子, 大江一弘, 永田光知郎, 寺本高啓, 市村 聡一朗, 中川創太, 吉村崇, 豊嶋厚史, 篠原厚. 水溶液中におけるボロノ基-アスタチン交換反応の特異性の解明. 日本放射化学会第63回討論会, 9/24-26, P12, Iwaki, Japan 2019.9.25. (Poster)
  3. Obata H, Minegishi K, Nagatsu K, Zhang MR, Toyoshima A, Shinohara A. Production of 191Pt from an iridium target.. The 10th China-Japan-Korea Symposium on Radiopharmaceutical Sciences, 2018/11/2-4, P322, Xiamen, China (Oral)
  4. 尾幡穂乃香, 峯岸克行, 永津弘太郎, 張明栄, 篠原厚. 191Pt製造法の開発. 第2回日本核医学会分科会放射薬品科学研究会, Tokyo, Japan, 2018.9. (Oral)

Others

  1. 尾幡穂乃香. 水溶液中におけるボロノ基-アスタチン交換反応の特異性の解明. 和分誌「放射化学」 (日本放射化学会), 2020, 41, 44-45.
  2. 尾幡穂乃香. リスクコミュニケーションを大切に. 月刊エネルギーレビュー ((株)エネルギーレビューセンター), 2019, 458, 13-14.
  3. 研究費助成制度「ジェネ・グラント」採択 (課題名: 標的アイソトープ療法に向けた放射線プラチナの標識検討及び生物評価).